ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,629 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryNyonHartis-Pharma SA
Hartis-Pharma SA Logo
Verified· 2 sourcesTrust Score
Summary

About the company

The core activity of HARTIS Pharma consists of researching and developing therapeutics based on the potential benefits of High-Density-Lipoprotein (HDL), particularly through the regulation of membrane cholesterol and its liposoluble cargo activity of antioxidants. The company focuses on developing treatments for medical needs that have not been adequately addressed or cannot be treated sufficiently.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
✓ Offered4
Development of therapeutics for sickle cell disease
Development of oral and injectable active ingredients for the treatment of sickle cell disease, including HRT-001 for chronic SCD and HRT-002 for vaso-occlusive crises.
Development of HDL-based therapies
Revisiting the therapeutic potential of HDL to regulate cholesterol in the red blood cell membrane as well as to reduce oxidation and hemoglobin polymerisation.
Development of therapies for sickle cell trait and related pathologies
Investigation of potential therapeutic approaches for sickle cell trait as well as applications in thalassaemia, microcirculation and type 2 diabetes.
Development of antioxidant and lipophilic vitamin transport therapies
Transport of liposoluble vitamins and antioxidants with possible applications in skin conditions, age-related macular degeneration, Alzheimer and neurodegenerative diseases.
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Hartis-Pharma SA

Trust & reputation

ranQ Trust Score of Hartis-Pharma SA: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

Without public customer reviews the score stays capped.

Hartis-Pharma SA has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Hartis-Pharma SA scores 83.5 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.86.512%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.70.07%
Hartis-Pharma SA scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
Hartis-Pharma SA scores 2.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.2.04%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Hartis-Pharma SA reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Hartis-Pharma SA has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Hartis-Pharma SA in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Hartis-Pharma SA by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Hartis-Pharma SA to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Chemin de Bonmont 13 C
1260 Nyon

At a glance

Legal form
Corporation
UID
CHE-293.248.994
Founded
2016 · 10 years
Last commercial register change
May 18, 2018
Employees
11 to 20
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    TP
    Tigen Pharma SA
    Lausanne
    FP
    Floratek Pharma SA
    Belmont-Sur-Lausanne
    ES
    Exciva Switzerland SA
    Epalinges
    AS
    Asceneuron SA
    Eysins
    VS
    Vandria SA
    Epalinges
    AI
    AC Immune SA
    Lausanne
    AÀ
    ANABIOTEC, à Evergem, succursale de Epalinges (VD)
    Epalinges
    RS
    ReproNovo SA
    Lausanne